364 related articles for article (PubMed ID: 28526632)
1. Erythrocytosis Following Testosterone Therapy.
Ohlander SJ; Varghese B; Pastuszak AW
Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
[TBL] [Abstract][Full Text] [Related]
2. Alternatives to Testosterone Therapy: A Review.
Lo EM; Rodriguez KM; Pastuszak AW; Khera M
Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
[TBL] [Abstract][Full Text] [Related]
3. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male.
Jones SD; Dukovac T; Sangkum P; Yafi FA; Hellstrom WJ
Sex Med Rev; 2015 Apr; 3(2):101-112. PubMed ID: 27784544
[TBL] [Abstract][Full Text] [Related]
4. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
5. Risk of Erythrocytosis During Concomitant Testosterone and SGLT2-Inhibitor Treatment: A Warning From Two Clinical Cases.
Motta G; Zavattaro M; Romeo F; Lanfranco F; Broglio F
J Clin Endocrinol Metab; 2019 Mar; 104(3):819-822. PubMed ID: 30395251
[TBL] [Abstract][Full Text] [Related]
6. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
Traish AM
Sex Med Rev; 2018 Jan; 6(1):86-105. PubMed ID: 29128268
[TBL] [Abstract][Full Text] [Related]
7. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
[TBL] [Abstract][Full Text] [Related]
9. [Testosterone replacement therapy and cardiovascular risk].
Corona G; Dicuio M; Rastrelli G; Sforza A; Maggi M
G Ital Cardiol (Rome); 2017 Nov; 18(11):745-753. PubMed ID: 29105668
[TBL] [Abstract][Full Text] [Related]
10. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
11. Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.
Aghazadeh M; Pastuszak AW; Johnson WG; McIntyre MG; Hsieh TM; Lipshultz LI
J Urol; 2015 Jul; 194(1):160-5. PubMed ID: 25596360
[TBL] [Abstract][Full Text] [Related]
12. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
13. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy and polycythemia in HIV-infected patients.
Vorkas CK; Vaamonde CM; Glesby MJ
AIDS; 2012 Jan; 26(2):243-5. PubMed ID: 22008652
[TBL] [Abstract][Full Text] [Related]
15. [Abdominal pain and hypertension in a 55-year-old male patient].
Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M
Internist (Berl); 2017 Apr; 58(4):397-401. PubMed ID: 28005140
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
18. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.
Ip FF; di Pierro I; Brown R; Cunningham I; Handelsman DJ; Liu PY
Eur J Endocrinol; 2010 Feb; 162(2):385-90. PubMed ID: 19903801
[TBL] [Abstract][Full Text] [Related]
19. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.
Conners WP; Morgentaler A
Curr Urol Rep; 2013 Dec; 14(6):557-64. PubMed ID: 23999611
[TBL] [Abstract][Full Text] [Related]
20. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
Khera M; Miner M; Jaffe J; Pastuszak AW
J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
